Diabetes may worsen quality of life for cancer patients on immunotherapy
NCT ID NCT07466212
First seen Mar 21, 2026 · Last updated May 23, 2026 · Updated 10 times
Summary
This observational study looks at how type 2 diabetes impacts quality of life in 920 cancer patients receiving immunotherapy. Participants will fill out surveys at the start, 3 months, and 6 months to track changes. The goal is to see if those with diabetes experience a greater decline in well-being during treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Afdeling for Kræftbehandling, Herlev Hospital
Herlev, 2730, Denmark
Contact Email: •••••@•••••
-
Kræftafdelingen, Aarhus Universitetshospital
Aarhus, 8000, Denmark
Contact
Contact Email: •••••@•••••
-
Onkologisk afdeling, Klinik Kirurgi og Kræftbehandling
Aalborg, 9000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sygehus Lillebælt, Onkologisk afdeling Vejle
Vejle, 7100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.